clinical trial led by the University of Michigan Kellogg Eye Center offers hope for those with moderate to severe active TED. Patients had a significant reduction in symptoms after treatment with teprotumumab, a study drug the Food and Drug Administration designated a “breakthrough therapy.”
labblog.uofmhealth.org/lab-...
I know not many here are affected this thyroid eye disease but for those who are this is incredibly uplifting news.